The invention concerns heliomicine, A DNA sequence coding for heliomicine, a
vector containing it for transfroming a host organism and the transformation method.
The invention concerns heliomicine as a medicine in particular for treating fungal
infections. More particularly, it concerns the transformation of plant cells and
plants, the heliomicine produced by the transformed plants ensuring their resistance
to diseases, in particular diseases of fungal origin.
